Development of a Population-Based Cancer Case-Control Study in Southern China

Weimin Ye,Ellen T Chang,Zhiwei Liu,Qing Liu,Yonglin Cai,Zhe Zhang,Guomin Chen,Qi-Hong Huang,Shang-Hang Xie,Su-Mei Cao,Jian-Yong Shao,Wei-Hua Jia,Yuming Zheng,Jian Liao,Yufeng Chen,Longde Lin,Liming Liang,Ingemar Ernberg,Thomas L Vaughan,Guangwu Huang,Yi Zeng,Yi-Xin Zeng,Hans-Olov Adami
DOI: https://doi.org/10.18632/oncotarget.19692
2017-01-01
Oncotarget
Abstract:With its population of over 1.3 billion persons, China offers abundant opportunities to discover causes of disease. However, few rigorous population-based case-control studies have as yet been conducted in mainland China. We conducted a population-based case-control study of nasopharyngeal carcinoma in Guangdong Province and Guangxi Autonomous Region. We collected questionnaires and biospecimens from incident cases recruited between March 2010 and December 2013, and population-based controls between November 2010 and November 2014. Preparatory activities prior to subject enrollment required approximately 18 months. We enrolled a total of 2554 NPC cases and 2648 controls. Among all identified cases, 83.8% participated. For the participating cases, the median time between diagnosis and interview was 2 days. Among all contacted controls, 82.7% participated. From the enrolled cases, we collected 2518 blood specimens (provided by 98.6% of eligible cases), 2350 saliva specimens (92.0%), 2514 hair specimens (98.4%), and 2507 toenail/fingernail specimens (98.2%). From the enrolled controls, we collected 2416 blood specimens (91.2%), 2505 saliva specimens (94.6%), 2517 hair specimens (95.1%), and 2514 toenail/fingernail specimens (94.9%). We demonstrate that population-based epidemiologic research can successfully be conducted in southern China. The study protocols, databases, and biobank will serve as an extraordinarily valuable resource for testing future etiologic hypotheses.
What problem does this paper attempt to address?